Why Choose Illingworth Research?
At Illingworth Research Group, our staff have many years’ experience in providing a wide range of clinical development services to the pharmaceutical, biotechnology and medical device industries. We have a wealth of experience in many therapeutic areas and in particular, respiratory, dermatology and rare disease. Below are some of CRO testimonials which relate to a range of services and therapeutic areas.
Feedback in relation to monitoring which Illingworth completed for a phase I study: “Thanks for all your help on this study and it was nice to have known such an excellent person nonetheless a self-motivated CRA!”
Comments to a member of the CRA team working on a phase I dermatology study in healthy subjects: “We are going to require monitoring services for a study that we will be managing and from the professionalism showed by yourself, we immediately thought of Illingworth Research for this task”.
Feedback to the CRA team working on a Haematology study: “I would like to thank you both very much for the excellent cooperation; we would really like to work with you again”.
Comments to Illingworth Project Manager, after the UK study management and monitoring of a European phase II Asthma study: “Only with your considerable efforts, great energy, friendship, support and assisting our team to stay on track and on meet our goals, we have successfully finished the project. Your contribution to the project evolution has been magnificent and without your hard work, this project would never have been completed as successfully as it has been. We would like to thank you for the fantastic working relationship we have had over the past two years. We have really enjoyed working with you and we do hope to have an opportunity of working with you again in the near future!”
Feedback from the Medical Director regarding the monitoring of a phase I single ascending dose study with a new compound for pain management:
“Your Project Manager has been working together with our research team from the beginning of the study and has demonstrated a very professional way to manage her role, and seamlessly integrate with the members of the team. We work with many external monitors considering we run around 30 phase I studies per year, however I can comment that your performance is above what we observe from other monitors. We are pleased with the quality of her work and her ability to communication effectively with the team”.
Feedback to the CRA team working on a CNS study: “We have worked with Illingworth CRAs before. They [Illingworth Research] have the best CRAs I have worked with!”
Feedback to Illingworth CRA, after monitoring of a diabetic study: “Your work and commitment to this project has certainly been top-notch, and we appreciate your dedication and integrity”.
Regarding an MREC application for a phase II dermatology study: “I only wish that more of the applications I get to review on my REC were as well thought out as this one”.